Bryan Hanson Net Worth

The estimated Net Worth of Bryan C Hanson is at least $28.5 Milion dollars as of 21 February 2023. Mr. Hanson owns over 15,132 units of Zimmer Biomet Inc stock worth over $11,308,777 and over the last 10 years he sold ZBH stock worth over $6,031,460. In addition, he makes $11,176,700 as President, Chief Executive Officer oraz Director at Zimmer Biomet Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Hanson ZBH stock SEC Form 4 insiders trading

Bryan has made over 25 trades of the Zimmer Biomet Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 15,132 units of ZBH stock worth $1,591,130 on 21 February 2023.

The largest trade he's ever made was exercising 58,470 units of Zimmer Biomet Inc stock on 19 December 2021 worth over $6,148,121. On average, Bryan trades about 6,197 units every 52 days since 2015. As of 21 February 2023 he still owns at least 107,549 units of Zimmer Biomet Inc stock.

You can see the complete history of Mr. Hanson stock trades at the bottom of the page.

Bryan Hanson biography

Bryan C. Hanson is President, Chief Executive Officer, Director of the Company. Previously, Mr. Hanson served as Executive Vice President and President, Minimally Invasive Therapies Group of Medtronic plc from January 2015 until joining Zimmer Biomet. Prior to that, he was Senior Vice President and Group President, Covidien of Covidien plc from October 2014 to January 2015; Senior Vice President and Group President, Medical Devices and United States of Covidien from October 2013 to September 2014; Senior Vice President and Group President of Covidien for the Surgical Solutions business from July 2011 to October 2013; and President of Covidien’s Energy-based Devices business from July 2006 to June 2011.

What is the salary of Bryan Hanson?

As the President, Chief Executive Officer oraz Director of Zimmer Biomet Inc, the total compensation of Bryan Hanson at Zimmer Biomet Inc is $11,176,700. There are no executives at Zimmer Biomet Inc getting paid more.

How old is Bryan Hanson?

Bryan Hanson is 53, he's been the President, Chief Executive Officer oraz Director of Zimmer Biomet Inc since 2017. There are 12 older and 9 younger executives at Zimmer Biomet Inc. The oldest executive at Zimmer Biomet Holdings Inc is Larry Glasscock, 72, who is the Independent Non-Executive Chairman of the Board.

What's Bryan Hanson's mailing address?

Bryan's mailing address filed with the SEC is C/O WALGREENS BOOTS ALLIANCE, INC., 108 WILMOT ROAD, DEERFIELD, IL, 60015.

Insiders trading at Zimmer Biomet Inc

Over the last 9 years, insiders at Zimmer Biomet Inc have traded over $2,148,754,462 worth of Zimmer Biomet Inc stock and bought 59,988 units worth $7,136,091 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Michael W Michelson oraz Group Inc Blackstone Group .... On average, Zimmer Biomet Inc executives and independent directors trade stock every 19 days with the average trade being worth of $14,226,269. The most recent stock trade was executed by Zuilen Wilfred Van on 1 July 2024, trading 2,633 units of ZBH stock currently worth $276,860.

What does Zimmer Biomet Inc do?

zimmer biomet is the world’s most trusted brand for personalized bone and joint healthcare solutions. we help people discover and achieve exceptional outcomes. as a leading innovator in musculoskeletal healthcare, we offer a complete portfolio of products for joint reconstruction, bone and skeletal repair, sports medicine, spine, and dental reconstruction. every day, we focus on improving musculoskeletal healthcare. it’s all we do. it’s all we’ve ever done. for nearly 90 years, zimmer biomet has helped people progress beyond their pain and limitations. because it’s not just what we make, it’s what we make possible. zimmer biomet serves healthcare professionals and their patients globally. our worldwide headquarters is in warsaw, indiana, usa.

Complete history of Mr. Hanson stock trades at Walgreens Boots Alliance Inc, 3M Co, Medtronic Plc oraz Zimmer Biomet Inc

Zimmer Biomet Inc executives and stock owners

Zimmer Biomet Inc executives and other stock owners filed with the SEC include:

• Bryan Hanson,
  President, Chief Executive Officer, Director
• Suketu Upadhyay,
  Chief Financial Officer, Executive Vice President
• Ivan Tornos,
  Group President - Global Businesses and Americas
• Didier Deltort,
  President - Europe, Middle East and Africa
• Bryan C. Hanson,
  Chairman, Pres & CEO
• Chad Phipps,
  Senior Vice President, General Counsel, Secretary
• Sang Yi,
  President, Asia Pacific
• Ivan Tornos,
  Group Pres of Global Bus.es, The Americas & EMEA Region and COO
• Suketu P. Upadhyay,
  Exec. VP & CFO
• Sang Yi,
  Group Pres of Asia Pacific
• Larry Glasscock,
  Independent Non-Executive Chairman of the Board
• Robert Hagemann,
  Independent Director
• Arthur Higgins,
  Independent Director
• Betsy Bernard,
  Independent Director
• Christopher Begley,
  Independent Director
• Gail Boudreaux,
  Independent Director
• Michael Farrell,
  Independent Director
• Michael Michelson,
  Independent Director
• Maria Hilado,
  Independent Director
• Syed Jafry,
  Independent Director
• Carrie Nichol,
  Chief Accounting Officer, Vice President, Controller
• Keri Mattox,
  Senior Vice President - Investor Relations, Chief Communications Officer
• Angela Main,
  Sr. VP, Global Chief Compliance Officer & Associate Gen. Counsel of Asia Pacific
• Chad F. Phipps,
  Sr. VP, Gen. Counsel & Sec.
• Zeeshan Tariq,
  Sr. VP & Chief Information Officer
• Dr. Nitin Goyal M.D.,
  Chief Science, Technology & Innovation Officer
• Derek M. Davis,
  Interim Controller, Chief Accounting Officer, & Principal Accounting Officer
• Louis Shapiro,
  Director
• David C Dvorak,
  President and CEO
• Paul Bisaro,
  Director
• David A. Jr. Nolan,
  Group President
• Adam Rudolph Johnson,
  Group President
• Cecil B Pickett,
  Director
• Katarzyna Mazur Hofsaess,
  Pres., Eur., M. East & Afr.
• Robert D. Delp,
  President, Americas
• Tony W. Collins,
  VP, Controller and CAO
• Jeffrey K. Rhodes,
  Director
• Daniel E. Williamson,
  Group President
• Zuilen Wilfred Van,
  Group Pres, EMEA
• Rachel Ellingson,
  SVP & Chief Strategy Officer
• Aure Bruneau,
  Group President
• Daniel P Florin,
  Exec. VP, CFO
• Sachs Group Incgoldman Sach...,
  
• Stuart G. Kleopfer,
  President, Americas
• Equity Partners 2004 Direct...,
  
• Group Holdings (Sbs) Adviso...,
  
• Group Inc Blackstone Group ...,
  
• Group L.P.Blackstone Manage...,
  
• Capital Partners V L P Blac...,
  
• Acquisition Holding, Llc Lvb,
  
• Sreelakshmi Kolli,
  Director
• Lori Winkler,
  SVP and CHRO
• Devdatt Kurdikar,
  Director
• Derek M Davis,
  Interim Controller & CAO
• Paul A Stellato,
  VP, Controller & CAO
• Mark Bezjak,
  President, Americas